Pfizer, Truveta join hands to accelerate safety insights in real time Ruchika Sharma22 Jun 2022 4:00 PM ISTBellevue: Truveta has announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable...
Pfizer to acquire 8.1 percent stake in Valneva Ruchika Sharma20 Jun 2022 10:30 AM ISTValneva is planning to use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program.
Walmart, pharmacy chains plan to vaccinate young children with COVID shots after authorization Ruchika Sharma19 Jun 2022 10:00 AM ISTA spokesperson for Walmart said the retail giant and its unit Sam's Club plan to begin vaccinating children as young as 3.
Pfizer, Moderna COVID vaccines get USFDA emergency use nod for kids as young as 6 months MD Bureau18 Jun 2022 12:30 PM ISTThe FDA said its evaluation and analysis of the safety, effectiveness and manufacturing data of these vaccines was rigorous and comprehensive,...
Pfizer halts COVID drug Paxlovid trial for standard-risk population Ruchika Sharma16 Jun 2022 2:47 PM ISTThe new data, however, showed a 51% relative risk reduction in standard-risk groups, which the company said was not statistically significant.
CCI nod to acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings (JVCO) Ruchika Sharma15 Jun 2022 2:15 PM ISTNew Delhi: The Competition Commission of India (CCI) approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings...
Pfizer, MorphoSys and Incyte enter trial collaboration for Monjuvi in combination with TTI-622 Ruchika Sharma15 Jun 2022 10:00 AM ISTUnder the terms of the agreement, Pfizer will initiate a multicenter, international Phase 1b/2 study of TTI-622 with Monjuvi and lenalidomide for...
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 1:45 PM ISTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Pfizer India launches free-of-cost online education platform on AMR for nurses Ruchika Sharma11 Jun 2022 12:26 PM ISTThe classes are available for all nurses, at different designations and levels of education and professional experience, from students to...
Pfizer Myfembree sNDA accepted by USFDA for review Ruchika Sharma6 Jun 2022 2:15 PM ISTMYFEMBREE was approved in the U.S. in 2021 for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women with...
Pfizer appoints Annaliesa Anderson as Senior Vice President Ruchika Sharma4 Jun 2022 4:52 PM ISTNew York: Pfizer Inc. has announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine...
Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status Ruchika Sharma3 Jun 2022 1:17 PM ISTPfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...
